Hongqi Chen

机构：Nanjing University of Chinese Medicine, University of Pittsburgh, Shanghai Jiao Tong University, Anyang Academy of Agricultural Sciences, Shanghai Sixth People's Hospital, Hunan University of Finance and Economics · ORCID：0000-0003-3073-020X

发表论文 86 篇 · 总被引 4283 次 · h-index 34

代表论文

• Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation (2022 · Journal for ImmunoTherapy of Cancer · 被引 104)
• Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer (2023 · Journal of Pharmaceutical Analysis · 被引 55)
• CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction (2022 · Acta Pharmaceutica Sinica B · 被引 42)
• Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy (2022 · Biomedicines · 被引 35)
• Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model (2024 · Journal of Translational Medicine · 被引 30)
• Targeting MAPK14 by Lobeline Upregulates Slurp1‐Mediated Inhibition of Alternative Activation of TAM and Retards Colorectal Cancer Growth (2025 · Advanced Science · 被引 24)